WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Leap Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason BaumChief Scientific Officer2025-03-286,604$0.32
$2.09kSell
Christine GranfieldVP Head of Reg AffairsQual2025-03-286,604$0.32
$2.09kSell
Augustine LawlorChief Operating Officer2025-03-287,797$0.32
$2.47kSell
Christopher MirabelliChairman of the Board2025-03-286,672$0.32
$2.12kSell
Douglas E. OnsiCEOCFOPres.GCTreas.Sec.2024-11-132,136$2.82
$6.02kBuy
James H. CavanaughDirector2024-11-13213$2.82
$600.66Buy
Christopher MirabelliChairman of the Board2024-11-132,136$2.82
$6.02kBuy
Augustine LawlorChief Operating Officer2024-11-132,136$2.82
$6.02kBuy

1 of 1

LPTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LPTX insiders and whales buy or sell their stock.

LPTX Shareholders

What type of owners hold Leap Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC20.55%8,476,496$3.36MInsider
Beigene Ltd17.81%7,348,437$2.91MInsider
Gilead Sciences Inc12.89%5,319,148$2.11MInsider
Gilead Sciences Inc12.89%5,319,148$2.11MInstitution
Healthcare Ventures IX LP10.05%4,144,804$1.64MInsider
John W. Littlechild6.35%2,618,406$1.04MInsider
Samsara Biocapital LLC5.92%2,442,352$967.17kInstitution
Augustine Lawlor4.17%1,718,454$680.51kInsider
Douglas E. Onsi3.74%1,542,971$611.02kInsider
Lilly Co Eli3.59%1,479,307$585.81kInsider

1 of 3

LPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LPTX35.95%64.05%Net SellingNet Selling
NRXS5.54%37.14%Net BuyingNet Buying
CING1.20%98.80%Net Selling
AFMD17.10%0.00%
ABVC1.91%98.09%
View Top Biotech Stocks

Leap Therapeutics Stock Ownership FAQ

Who owns Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is owned by 46.87% institutional shareholders, 83.51% Leap Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Leap Therapeutics shareholder, owning 8.48M shares representing 20.55% of the company. Perceptive Advisors LLC's Leap Therapeutics shares are currently valued at $3.28M.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.